Fifteen-fraction central-boost planning was feasible for bulky retroperitoneal sarcoma
All 15 replans met target coverage, but one-third exceeded at least one bowel objective and kidney constraints remained challenging.
All 15 replans met target coverage, but one-third exceeded at least one bowel objective and kidney constraints remained challenging.
Preoperative radiotherapy was not associated with greater renal dysfunction after nephrectomy for retroperitoneal sarcoma during follow-up extending to 80 months.